TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.30$ -0.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Zhengye Biotechnology Holding Limited (ZYBT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 436 million CNY. Tick rows to compare them in a chart.

All figures in millions of CNY.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZYBT
Line item 2021 2022 2023 2024 2025
445 520 500 493 436
165 214 206 178 137
6.3 9.7 15 19 50
6.3 9.7 16 – 52
102 134 99 60 18
44 55 58 58 39
12 19 16 23 55
126 163 161 141 130
126 152 150 136 120
30 55 80 – 66
78 79 46 43 44
– 10.0 10.0 4.8 8.9
267 296 273 284 250
42 66 38 48 -22
47 47 47 47 47

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?